A randomized, open-label, single dose, 4-period replicate crossover study to evaluate the pharmacokinetic profiles and safety of CKD-828 in healthy volunteers under fasting conditions
A clinical trial to compare the pharmacokinetic and safety of CKD-828 20/1.25mg